Literature DB >> 15479850

Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.

Dongsheng Li1, William B Lott, John Martyn, Gholamreza Haqshenas, Eric J Gowans.   

Abstract

To investigate the role of the hepatitis C virus internal ribosome entry site (HCV IRES) domain IV in translation initiation and regulation, two chimeric IRES elements were constructed to contain the reciprocal domain IV in the otherwise HCV and classical swine fever virus IRES elements. This permitted an examination of the role of domain IV in the control of HCV translation. A specific inhibitor of the HCV IRES, vitamin B(12), was shown to inhibit translation directed by all IRES elements which contained domain IV from the HCV and the GB virus B IRES elements, whereas the HCV core protein could only suppress translation from the wild-type HCV IRES. Thus, the mechanisms of translation inhibition by vitamin B(12) and the core protein differ, and they target different regions of the IRES.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479850      PMCID: PMC523236          DOI: 10.1128/JVI.78.21.12075-12081.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Internal ribosome entry site-mediated translation in hepatitis C virus replication.

Authors:  R C Rijnbrand; S M Lemon
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

3.  A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs.

Authors:  T V Pestova; I N Shatsky; S P Fletcher; R J Jackson; C U Hellen
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

4.  GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.

Authors:  E Scarselli; A Urbani; A Sbardellati; L Tomei; R De Francesco; C Traboni
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease.

Authors:  M Oketani; Y Asahina; C H Wu; G Y Wu
Journal:  J Hepatol       Date:  1999-10       Impact factor: 25.083

6.  Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation.

Authors:  T Shimoike; S Mimori; H Tani; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo.

Authors:  R Gosert; K H Chang; R Rijnbrand; M Yi; D V Sangar; S M Lemon
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Internal entry of ribosomes is directed by the 5' noncoding region of classical swine fever virus and is dependent on the presence of an RNA pseudoknot upstream of the initiation codon.

Authors:  R Rijnbrand; T van der Straaten; P A van Rijn; W J Spaan; P J Bredenbeek
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Cell clones selected from the Huh7 human hepatoma cell line support efficient replication of a subgenomic GB virus B replicon.

Authors:  Amedeo De Tomassi; Maura Pizzuti; Rita Graziani; Andrea Sbardellati; Sergio Altamura; Giacomo Paonessa; Cinzia Traboni
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus.

Authors:  B Hahm; Y K Kim; J H Kim; T Y Kim; S K Jang
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  7 in total

Review 1.  Role of vitamins in gastrointestinal diseases.

Authors:  Omar A Masri; Jean M Chalhoub; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 2.  Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

Authors:  Tzu-Hao Lee; Hans L Tillmann; Keyur Patel
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

3.  Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA.

Authors:  Masahiko Takeshita; Yo-Ichi Ishida; Ena Akamatsu; Yusuke Ohmori; Masayuki Sudoh; Hirofumi Uto; Hirohito Tsubouchi; Hiroaki Kataoka
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

4.  Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study.

Authors:  Nicolae-Catalin Mechie; Armin D Goralzcyk; Lars Reinhardt; Sabine Mihm; Ahmad Amanzada
Journal:  BMC Res Notes       Date:  2015-06-25

5.  HCV IRES-mediated core expression in zebrafish.

Authors:  Ye Zhao; Wei Qin; Jing-Pu Zhang; Zhan-Ying Hu; Jun-Wei Tong; Cun-Bao Ding; Zong-Gen Peng; Li-Xun Zhao; Dan-Qing Song; Jian-Dong Jiang
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

6.  Characterization of a Novel Tanay Virus Isolated From Anopheles sinensis Mosquitoes in Yunnan, China.

Authors:  Lu Zhao; Caroline Mwaliko; Evans Atoni; Yujuan Wang; Yunzhi Zhang; Jianbo Zhan; Xiaomin Hu; Han Xia; Zhiming Yuan
Journal:  Front Microbiol       Date:  2019-08-22       Impact factor: 5.640

7.  Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.

Authors:  Wei Zhu; Miao Xu; Catherine Z Chen; Hui Guo; Min Shen; Xin Hu; Paul Shinn; Carleen Klumpp-Thomas; Samuel G Michael; Wei Zheng
Journal:  bioRxiv       Date:  2020-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.